Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Clinical trial NCT02887625 · UNKNOWN

Trial details

NCT number: NCT02887625
Sponsor: Dr. Muhammad Abdulghani
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2015-02-01
Primary completion: 2017-05-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.